Placeholder

Alkermes

Account Based Marketing (ABM) segment for B2B targeting people who work at Alkermes in the Biotechnology industry.  Feel free to add as many companies you like to the shopping cart and we will assist you in activating your campaign in the marketing platforms you choose. Alkermes has over   2241. AccountsGraph by Skydeo has 5,831 users available for digital targeting and 1,752 contacts with emails, titles, phone, address, LinkedIn URLs, etc. to update your CRM for account-based marketing.

You may reference segment ID – 500700787 or by name *AccountsGraph.com > Biotechnology > Alkermes.

About Alkermes: Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.. alkermes.com

SIC CODE:

AccountsGraph taxonomy is available for Google, Facebook, TikTok, Snapchat, The Trade Desk, Verizon Media Yahoo, and many more via LiveRamp.  Please contact us if  you have any questions.

SKU 500700787 Category Tags ,